Mark Cutler

6.2k citations
24 papers · 1000 · 2 hit papers · h-index 13

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 detection and testing
    • Viral gastroenteritis research and epidemiology
    • Animal Virus Infections Studies

Papers in

    • SARS-CoV-2 and COVID-19 Research 8
    • SARS-CoV-2 detection and testing 4
    • COVID-19 Clinical Research Studies 3
    • Viral Infections and Outbreaks Research 2
    • Pneumonia and Respiratory Infections 7
    • Respiratory viral infections research 4

Mark Cutler

22 papers receiving 976 citations

Mark Cutler's Hit Papers

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants 2021 · 213 citations
2130+1+3Years since publication100200300

Peers

Mark Cutler
Comparison fields: 5 of 83
  • Infectious Diseases 727
  • Animal Science and Zoology 138
  • Health 85
  • Obstetrics and Gynecology 55
  • Microbiology 45
Replace Karin van den Berg with:
Karin van den Berg South Africa
Pieter Neels Belgium
Bassam Hallis United Kingdom
Christine Laurent France
Kathryn Lanza United States
Alexis C. R. Hoste Belgium
Julie Garon United States
David Peterhoff Germany
Ronald LW Ko Hong Kong
Mark Cutler relative to Karin van den Berg South Africa Karin van den Berg's profile →
Citations per field
00.5×3.7×
Karin van den Berg · 1×
Citations per year

Countries citing papers authored by Mark Cutler

Since Specialization
Citations

This map shows the geographic impact of Mark Cutler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cutler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cutler more than expected).

Fields of papers citing papers by Mark Cutler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Cutler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cutler. The network helps show where Mark Cutler may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Cutler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Cutler Line = papers co-authored together Mark Cutler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Hit paper breakdown →
2021387
2
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Hit paper breakdown →
2021213
3 202265
4 202157
5 202243
6 199837
7 202129
8 202229
9 200420
10 199218
11 198618
12 201714
13 202014
14 201511
15 202010
16 19889
17 20227
18 20196
19 20205
20 20173

About Mark Cutler

Mark Cutler is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Animal Science and Zoology and Health, Toxicology and Mutagenesis, having authored 24 papers that have together received 1000 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Pneumonia and Respiratory Infections (7 papers), Bacterial Infections and Vaccines (6 papers), Animal Virus Infections Studies (5 papers), SARS-CoV-2 detection and testing (4 papers), Respiratory viral infections research (4 papers), COVID-19 Clinical Research Studies (3 papers) and Viral Infections and Outbreaks Research (2 papers). The work is most often cited by research in Infectious Diseases (727 citations), Animal Science and Zoology (138 citations), Health (85 citations), Obstetrics and Gynecology (55 citations) and Microbiology (45 citations). Mark Cutler has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include David Cooper, Kena A. Swanson, Xuping Xie, Jing Zou, Pei‐Yong Shi, Hongjie Xia, Philip R. Dormitzer, Scott C. Weaver, Camila R. Fontes-Garfias and Xianwen Zhang. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, npj Vaccines, Neuropharmacology and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact